| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/22/2002 | CN1350452A Preventive or therapeutic drugs for diabetes |
| 05/22/2002 | CN1350447A Antiperspirant and deodorant compositions containing cyclonexasiloxane |
| 05/22/2002 | CN1350445A Treatment of hepatitis C using hyperthermia |
| 05/22/2002 | CN1350435A A composition containing carvacrol and thymol for use as abactericide |
| 05/22/2002 | CN1349989A 4-hydroxyl-piperidine derivative |
| 05/22/2002 | CN1349983A Non-peptide neomatal vascularization inhibitor |
| 05/22/2002 | CN1349965A Fatty amido substituted desmethoxy hypocrellin with fatty ring or aromatic ring and its synthesis and application |
| 05/22/2002 | CN1349821A Pharyngitis treating Chinese medicine plaster |
| 05/22/2002 | CN1349820A Application of shinyleaf yellowhorn fruit shell in preparing cerbral function improving food and medicine |
| 05/22/2002 | CN1349812A Composite medicine for treating myocardosis and its prepn |
| 05/22/2002 | CN1349806A Hypoglycemic and antiphthitic medicine for treating diabetes and phthisis |
| 05/22/2002 | CN1349796A Pyrrole derivatives and medicine composition |
| 05/22/2002 | CN1349795A Compound slimming prepn and its application |
| 05/22/2002 | CN1349757A Health foods |
| 05/22/2002 | CN1085250C Enzymatic hydroxylation process for the preparation HMG-CoA reductase inhibitors and intermediates thereof |
| 05/22/2002 | CN1085213C Triazole derivatives useful in therapy |
| 05/22/2002 | CN1085212C Rapamycin 42-oximes and hydroxylamines |
| 05/22/2002 | CN1085211C Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 05/22/2002 | CN1085208C Process for preparing eprosartan |
| 05/22/2002 | CN1085206C Benzofurazan compounds which enhance AMPA receptor activity |
| 05/22/2002 | CN1085205C Bicyclic amino acids |
| 05/22/2002 | CN1085099C Medicine for treating thyroid enlargement thyrodism |
| 05/22/2002 | CN1085087C External used ointment for curing dermatosis, venereal disease and AIDS and preparation method thereof |
| 05/22/2002 | CN1085082C Medicine for curing arrhythmic coronary heart disease and producing method thereof |
| 05/22/2002 | CN1085081C Compound fish oil |
| 05/22/2002 | CN1085080C Medicine for treating and preventing saturnism and its preparing process |
| 05/22/2002 | CN1085079C Use of granisetron for the treatment of post-operative hausea and uomitting |
| 05/22/2002 | CN1085078C Medicine composition for odinopoenia of long pregnancy |
| 05/21/2002 | US6392100 Antiinflammatory agents; antiproliferative agents; immunosuppressants; viricides |
| 05/21/2002 | US6392087 Monohydric alcohol derived urethanes and their use in cosmetic formulations |
| 05/21/2002 | US6392085 Therapeutic nucleosides |
| 05/21/2002 | US6392082 Triazole derivatives having antifungal activity |
| 05/21/2002 | US6392069 Compositions for enhancing delivery of nucleic acids to cells |
| 05/21/2002 | US6392068 Carborane containing cholesterol, a new type of molecule for targeted boron drug delivery |
| 05/21/2002 | US6392053 Process for preparing arylacetylaminothiazoles |
| 05/21/2002 | US6392045 9-azobicyclo[3.3.1] non-2-ene derivatives as cholinergic ligands at nicotinic ACH receptors |
| 05/21/2002 | US6392042 Polyhydroxyalkylpyrazine derivatives, their preparation and medicaments comprising them |
| 05/21/2002 | US6392039 Coupling; salt formation |
| 05/21/2002 | US6392038 Seeding solution of racemic mixture; dissolving in solvent; extraction |
| 05/21/2002 | US6392036 Sanitizing particles in sample; obtain sample, expose to heat, monitor sample for antiseptic nature |
| 05/21/2002 | US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
| 05/21/2002 | US6391924 Taurine derivatives useable in the treatment of ophthalmic disorders |
| 05/21/2002 | US6391922 Administering neurotransmitter |
| 05/21/2002 | US6391921 Treatment of inflammation with 2,4,6-trihydroxy-α-para-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives |
| 05/21/2002 | US6391920 Administering hormone inhibitor; stimulant of testosterone |
| 05/21/2002 | US6391917 Analgesic |
| 05/21/2002 | US6391914 Optically active aminopentane derivatives |
| 05/21/2002 | US6391911 Cancer therapy |
| 05/21/2002 | US6391910 Opioid antagonist; analgesic |
| 05/21/2002 | US6391909 Anandamide inhibitors as analgesic agents |
| 05/21/2002 | US6391908 Oxime amide indole type sPLA2 inhibitors |
| 05/21/2002 | US6391907 Anticancer agents; contraceptives |
| 05/21/2002 | US6391904 Bone disorders |
| 05/21/2002 | US6391903 Triazole derivatives having antifungal activity |
| 05/21/2002 | US6391901 Cardiovascular disorders; anticoagulants |
| 05/21/2002 | US6391900 Antitumor agents |
| 05/21/2002 | US6391899 Stroke therapy; cardiovascular disorders |
| 05/21/2002 | US6391897 (4'-benzofuran-3-yl-biphenyl-4-yloxy)-acetic acid, for example; inhibit protein-tyrosine phosphatases (ptpases) |
| 05/21/2002 | US6391896 3-Tetrahydropyridin-4-yl indoles for treatment of psychotic disorders |
| 05/21/2002 | US6391894 Myt1 kinase inhibitors |
| 05/21/2002 | US6391893 Anticancer agents |
| 05/21/2002 | US6391892 Naphthyl pharmaceutical compounds |
| 05/21/2002 | US6391891 Bicyclic compounds as ligands for 5-HT1 receptors |
| 05/21/2002 | US6391889 Potent antimicrobial activity on broad range of microorganisms, e.g., staphylococcus, grampositive bacteria and quinolone antibiotic resistance; side effect reduction; nontoxic |
| 05/21/2002 | US6391888 Topical anesthetics useful for treating cancer |
| 05/21/2002 | US6391887 3,4-Dihydroquinoline derivatives as nitrogen monoxide synthase (NOS) inhibitors |
| 05/21/2002 | US6391886 Oral compositions having improved consumer aesthetics |
| 05/21/2002 | US6391885 Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives |
| 05/21/2002 | US6391880 Anticholesterol agents |
| 05/21/2002 | US6391879 Therapeutic anti-fungal nail preparation |
| 05/21/2002 | US6391878 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer |
| 05/21/2002 | US6391876 Reboxetine for treatment obsessive compulsive disorders and panic disorder |
| 05/21/2002 | US6391875 Pharmaceutically active morpholinol |
| 05/21/2002 | US6391874 Anticarcinogenic agents; skin disorders |
| 05/21/2002 | US6391873 Anxiolytic agents; anticonvulsants; therapy for sleep disorders |
| 05/21/2002 | US6391872 Indazole bioisostere replacement of catechol in therapeutically active compounds |
| 05/21/2002 | US6391871 Preventing neuronal degeneration in Alzheimer's disease |
| 05/21/2002 | US6391870 Dopaminergic agent |
| 05/21/2002 | US6391869 Compositions and methods for the treatment of anorectal disorders |
| 05/21/2002 | US6391868 Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans |
| 05/21/2002 | US6391867 Use of spironolactone for treatment of symptomatic heart failure |
| 05/21/2002 | US6391866 Analgesics |
| 05/21/2002 | US6391865 Aids therapy; antiinflammatory agents; rheumatic diseases; skin disorders |
| 05/21/2002 | US6391864 Glucosamine mixtures |
| 05/21/2002 | US6391863 Use of carbohydrates for promoting skin desquamation |
| 05/21/2002 | US6391861 Administering hyaluronic acid |
| 05/21/2002 | US6391860 Skin disorders |
| 05/21/2002 | US6391854 Water soluble hypoglycemic agents |
| 05/21/2002 | US6391832 Medical emulsion for lubrication and delivery of drugs |
| 05/21/2002 | US6391631 Nucleotide sequences for use as tools in genetic engineering and analysis |
| 05/21/2002 | US6391616 Oidiodendron strain for the production of terpenoid lactone compounds |
| 05/21/2002 | US6391365 For foodstuffs, stimulants and oral hygiene products |
| 05/21/2002 | US6391344 By administering rosemary or sage extracts; carnosic acid, carnosol |
| 05/21/2002 | US6391342 Oral pharmaceutical formulation comprising granules having inert core coated with inner layer comprising benzimidazole, disintegrant and surfactant in matrix of glyceride melt coating substance, intermediate layer, enteric outer layer |
| 05/21/2002 | US6391341 Stable pellets containing inert core with spherical symmetry and specified diameter made of starch and sucrose, coated with active layer containing micronized piroxicam and excipients, with polymeric insulating layer and with enteric layer |
| 05/21/2002 | US6391340 Dry powder pharmaceutical formulation |
| 05/21/2002 | US6391339 Administering pentasaccharide anticoagulant |
| 05/21/2002 | US6391337 Transforming acetaminophen and direct compression vehicle into a homogenous granulate under high shear conditions without degradation; microcystalline cellulose vehicle and lubricant |
| 05/21/2002 | US6391336 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 05/21/2002 | US6391334 Barrier-forming composition |